IMS Health Holdings (NYSE:IMS) : Traders are bullish on IMS Health Holdings (NYSE:IMS) as it has outperformed the S&P 500 by a wide margin of 6.82% in the past 4 weeks. The bullishness in the stock continues even in the near-term as the stock has returned an impressive 4.75%, relative to the S&P 500. The stock has continued its bullish performance both in the near-term and the medium-term, as the stock is up 6.09% in the last 1 week, and is up 8.55% in the past 4 weeks. Buying continues as the stock moves higher, suggesting a strong appetite for the stock.
The company shares have dropped -11.03% from its 1 Year high price. On Jul 31, 2015, the shares registered one year high at $33.52 and the one year low was seen on Jan 28, 2016. The 50-Day Moving Average price is $25.50 and the 200 Day Moving Average price is recorded at $25.31.
The stock has recorded a 20-day Moving Average of 9.83% and the 50-Day Moving Average is 8.95%.
IMS Health Holdings (NYSE:IMS): stock turned positive on Friday. Though the stock opened at $26.78, the bulls momentum made the stock top out at $27.82 level for the day. The stock recorded a low of $26.75 and closed the trading day at $27.68, in the green by 3.36%. The total traded volume for the day was 2,337,875. The stock had closed at $26.78 in the previous days trading.
In an insider trading activity,The officer (SVP, Information Offerings) of Ims Health Holdings, Inc., Knightly Kevin C sold 19,231 shares at $28.5 on November 23, 2015. The Insider selling transaction had a total value worth of $548,084. The Insider information was disclosed with the Securities and Exchange Commission in a Form 4 filing.
IMS Health Holdings, Inc. (IMS) is an information and technology services company that provides solutions to its clients in the healthcare industry. The Company has its presence in over 100 countries. The Companys data set contains over 10 petabytes of data and over 500 million patient records. The Company serves healthcare organizations and life science companies, including pharmaceutical, biotechnology, consumer health and medical device manufacturers, as well as distributors, providers, payers, government agencies, policymakers, researchers and the financial community. The Companys principal offerings include national information offerings, sub-national information offerings, workflow analytics, real-world evidence (RWE) solutions, technology and applications and clinical solutions.